Amedeo Smart

Free Medical Literature Service


 

Amedeo

Genetics

  Free Subscription

Articles published in
J Natl Cancer Inst
    August 2023
  1. HUEY RW, Shah AT, Reddi HV, Dasari P, et al
    Feasibility and value of genomic profiling in cancer of unknown primary: real-world evidence from prospective profiling study.
    J Natl Cancer Inst. 2023;115:994-997.
    >> Share

  2. WANG H, Ding XH, Liu CL, Xiao Y, et al
    Genomic alterations impacting tumor-infiltrating lymphocytes and PD-L1 expression patterns in triple-negative breast cancer.
    J Natl Cancer Inst. 2023 Aug 7:djad154. doi: 10.1093.
    >> Share

    June 2023
  3. FENG X, Wu WY, Onwuka JU, Haider Z, et al
    Lung cancer risk discrimination of prediagnostic proteomics measurements compared with existing prediction tools.
    J Natl Cancer Inst. 2023 Jun 1:djad071. doi: 10.1093.
    >> Share

    November 2022
  4. SAFDAR NS, Stasenko M, Selenica P, Martin AS, et al
    Genomic Determinants of Early Recurrences in Low-Stage, Low-Grade Endometrioid Endometrial Carcinoma.
    J Natl Cancer Inst. 2022;114:1545-1548.
    >> Share

    September 2022
  5. UMEMOTO K, Yamamoto H, Oikawa R, Takeda H, et al
    The Molecular Landscape of Pancreatobiliary Cancers for Novel Targeted Therapies From Real-World Genomic Profiling.
    J Natl Cancer Inst. 2022;114:1279-1286.
    >> Share

    August 2022
  6. WICKLAND DP, Sherman ME, Radisky DC, Mansfield AS, et al
    Lower Exome Sequencing Coverage of Ancestrally African Patients in The Cancer Genome Atlas.
    J Natl Cancer Inst. 2022;114:1192-1199.
    >> Share

    July 2022
  7. QING T, Mohsen H, Cannataro VL, Marczyk M, et al
    Cancer Relevance of Human Genes.
    J Natl Cancer Inst. 2022;114:988-995.
    >> Share

    February 2022
  8. TANAKA I, Dayde D, Tai MC, Mori H, et al
    SRGN-Triggered Aggressive and Immunosuppressive Phenotype in a Subset of TTF-1-Negative Lung Adenocarcinomas.
    J Natl Cancer Inst. 2022;114:290-301.
    >> Share

  9. HEIN DM, Deng W, Bleile M, Kazmi SA, et al
    Racial and Ethnic Differences in Genomic Profiling of Early-Onset Colorectal Cancer.
    J Natl Cancer Inst. 2022 Feb 2. pii: 6520467. doi: 10.1093.
    >> Share

    November 2021
  10. FOULKES WD, Polak P
    Li-Fraumeni Syndrome in the Cancer Genomics Era.
    J Natl Cancer Inst. 2021;113:1615-1617.
    >> Share

  11. FOUNTZILAS E, Kurzrock R, Vo HH, Tsimberidou AM, et al
    Wedding of Molecular Alterations and Immune Checkpoint Blockade: Genomics as a Matchmaker.
    J Natl Cancer Inst. 2021;113:1634-1647.
    >> Share

  12. EMENS LA
    Predictive Biomarkers: Progress on the Road to Personalized Cancer Immunotherapy.
    J Natl Cancer Inst. 2021;113:1601-1603.
    >> Share

    October 2021
  13. BAKSHI A, Yan M, Riaz M, Polekhina G, et al
    Genomic Risk Score for Melanoma in a Prospective Study of Older Individuals.
    J Natl Cancer Inst. 2021;113:1379-1385.
    >> Share

    September 2021
  14. VARGHESE AM, Singh I, Singh R, Kunte S, et al
    Early-Onset Pancreas Cancer: Clinical Descriptors, Genomics, and Outcomes.
    J Natl Cancer Inst. 2021;113:1194-1202.
    >> Share

    July 2021
  15. SEMBA T, Wang X, Xie X, Cohen EN, et al
    Identification of the JNK-Active Triple-Negative Breast Cancer Cluster Associated with an Immunosuppressive Tumor Microenvironment.
    J Natl Cancer Inst. 2021 Jul 12. pii: 6313157. doi: 10.1093.
    >> Share

    March 2021
  16. WEST CML
    Identifying the Radioresponsive Genome for Genomics-Guided Radiotherapy.
    J Natl Cancer Inst. 2021;113:223-224.
    >> Share

    May 2020
  17. YABROFF KR, Zhao J, de Moor JS, Sineshaw HM, et al
    Factors Associated With Oncologist Discussions of the Costs of Genomic Testing and Related Treatments.
    J Natl Cancer Inst. 2020;112:498-506.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016